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Proper function of the nervous system critically relies on sophisticated neuronal networks
interconnected in a highly specific pattern. The architecture of these connections
arises from sequential developmental steps such as axonal growth and guidance,
dendrite development, target determination, synapse formation and plasticity. Leucine-
rich repeat (LRR) transmembrane proteins have been involved in cell-type specific
signaling pathways that underlie these developmental processes. The members of this
superfamily of proteins execute their functions acting as trans-synaptic cell adhesion
molecules involved in target specificity and synapse formation or working in cis as
cell-intrinsic modulators of neurotrophic factor receptor trafficking and signaling. In this
review, we will focus on novel physiological mechanisms through which LRR proteins
regulate neurotrophic factor receptor signaling, highlighting the importance of these
modulatory events for proper axonal extension and guidance, tissue innervation and
dendrite morphogenesis. Additionally, we discuss few examples linking this set of LRR
proteins to neurodevelopmental and psychiatric disorders.
Keywords: leucine-rich repeat (LRR) proteins, neurotrophic factors, neuronal connectivity, axonal growth and
guidance, dendrite development, target innervation
INTRODUCTION
The establishment of a functional nervous system requires connecting neurons into complex
neuronal networks with exquisite precision. To achieve this, growing dendrites and axons must
navigate toward their target regions, recognize their appropriate target cells and establish specific
synaptic contacts with these cells. Along this pathway, dendrites and axons are guided by a group
of short- and long-range signals that help them sense and navigate the environment and establish
appropriate contacts with specific target cells.
Neurotrophic factors are a group of secreted and diffusible molecules that play a crucial
role in the development, survival and maintenance of the peripheral and central nervous
system. The two major families of neurotrophic factors are: the neurotrophins and the glial cell
line-derived neurotrophic factor (GDNF) family of ligands (GFLs; Reichardt, 2006; Paratcha
and Ledda, 2008; Bothwell, 2014; Ibañez and Andressoo, 2016). Neurotrophins constitute a
structurally-related family of proteins represented by nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF), neurotrophin 3 (NT3) and NT4, which were first identified
as survival factors for developing neurons. Later studies showed that they are pleiotropic
molecules that support a variety of functions including the control of axonal growth and
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guidance, dendrite development and synaptic plasticity
via the activation of their cell-surface receptor tyrosine
kinase (RTK) TrkA, TrkB and TrkC (Reichardt, 2006;
Shmelkov et al., 2010; Mariga et al., 2016). The extracellular
domains of the Trk receptors contain two cysteine-rich
clusters flanking three leucine-rich repeat (LRR) motives,
followed by two immunoglobulin (Ig)-like domains
in the juxtamembrane region (Windisch et al., 1995).
Binding and deletion studies on TrkA, TrkB and TrkC
indicate that one of the Ig-like domains is responsible for
neurotrophin binding (Pérez et al., 1995; Urfer et al., 1995;
Ultsch et al., 1999), with the leucine-rich domain having
a modulatory role in ligand interaction (Windisch et al.,
1995).
Neurotrophins are initially synthesized as pro-neurotrophins
precursors, which are cleaved to produce the mature protein.
Lee et al. (2001) described that pro-neurotrophins can be
secreted as precursors (Lee et al., 2001; Hempstead, 2014).
While mature neurotrophins bind to Trk receptors and the
presence of p75NTR increases the affinity of the Trk receptors
for their specific ligands, pro-neurotrophins bind to a p75NTR-
sortilin receptor complex to induce neuronal cell death
during development and pathological conditions (Hempstead,
2014).
GFLs are another family of neurotrophic factors that is
composed of GDNF, Neurturin (NRTN), Artemin (ARTN),
and Persephin (PSPN). GDNF was originally discovered
by its ability to induce the survival of ventral midbrain
dopaminergic neurons. Later work showed that GFLs control
growth and survival of specific subpopulations of motor neurons
and many peripheral neurons, including sympathetic and
sensory neurons. GFLs promote these trophic effects acting
through two types of receptor subunits, one specialized in
ligand binding, represented by the glycosyl-phosphatidylinositol
(GPI)-anchored co-receptor, GFRα and another involved in
transmembrane signaling, represented by the RTK, Ret or the
neural cell adhesion molecule (NCAM; Ibañez and Andressoo,
2016).
Trk and Ret receptors are expressed in specific subpopulations
of peripheral and central neurons, where they contribute to the
establishment of neuronal connections (Garcès et al., 2000;
Patel et al., 2003; Kramer et al., 2006; Wickramasinghe et al.,
2008). Although these receptors are expressed in specific
subset of neurons, they cannot by themselves explain the
complex pattern of neuronal connectivity that characterized the
vertebrate nervous system. In recent years, various genetically
modified mouse models have demonstrated that Trk and
Ret receptors need to be modulated by different proteins to
achieve cell type-specific responses to their cognate ligands
during circuit development. In this regard, LRR-containing
proteins have emerged as relevant partners of neurotrophic
factor receptors in specific populations of developing
neurons to provide fine tuned control over growth factor
signaling.
LRRs are 20–29 amino acid sequence motives present in a
number of proteins, which provide structural framework for
the formation of protein-protein interactions (Björklund et al.,
2006). During the last years, these protein interaction domains
have been shown to be critically involved in the control of
axonal elongation and navigation, target cell specificity, dendrite
development, synapse formation and plasticity. Interestingly,
these structural LRR motives are one of the domains more
widely maintained across evolution (Chen et al., 2006). The
N-terminal region of the repeat consists of a conserved
sequence rich in leucine at specified positions (LxxLxLxxNxL,
where x is any amino acid). From a structural point of
view, each LRR domain is composed of a β-strand connected
by a loop region to a α-helix motif roughly parallel to
the strand. These repeats commonly fold together to form
a curved structure that represent a large binding surface
domain, which makes the LRR domain a very effective protein-
binding motif (Kobe and Kajava, 2001). Variations in the
length and number of repeats affects curvature of the LRR
domain and this turn permits interactions with an enormous
diversity of ligands. Thus, the LRR domain is not only an
efficient but also a very versatile protein-protein interaction
domain. The presence of LRR domains in the ectodomain
architecture of the Trk neurotrophin receptors anticipated
the important roles played by LRR proteins during nervous
system development. Many LRR transmembrane proteins are
expressed at the synapses where they contribute to target
specificity and synapse formation working as trans-synaptic
cell adhesion molecules. In addition to this role as synaptic
organizers, growing evidence indicates that other LRR domain-
containing proteins act in cis modulating cell-surface receptor
signaling at different regions and stages of nervous system
development.
While flies lack homologs of Trk receptors, Ret is a conserved
RTK expressed in the nervous system of vertebrates (Pachnis
et al., 1993; Schuchardt et al., 1994; McIlroy et al., 2013)
and Drosophila (Sugaya et al., 1994; Hahn and Bishop, 2001).
Despite being a highly conserved molecule, Drosophila Ret
(dRet) receptor cannot be activated by their cognate vertebrate
GDNF ligands because they are not expressed in flies. However,
a recent work has shown novel functions for dRet as a
regulator of sensory neuron dendrite growth and patterning,
through a mechanism that requires signaling crosstalk with
integrins, but does not involve GDNF binding (Soba et al.,
2015). Thus, the emergence of neurotrophic factor receptor
components and ligands together with the diversification of
the LRR proteome across evolution suggest that neurotrophic
factor receptor signaling might be considered one of the
prerequisites for evolution of complex nervous systems (Dolan
et al., 2007).
Here, we review the current understanding of the
role of LRR domain-containing proteins as cell-intrinsic
regulators of neurotrophic factor receptor signaling required
for proper nervous system development. An overview
of the domain organization of LRR proteins regulating
neural circuit development through their interaction with
neurotrophic factor receptors is shown in Figure 1. For a
more comprehensive review that includes other LRR proteins
that function as synaptic organizers see the article from
de Wit and Ghosh (2014).
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FIGURE 1 | Overview of the domain organization of leucine-rich repeat (LRR) proteins regulating neural circuit development through their interaction
with guidance/neurotrophic factor receptors. The scheme shows neural LRR proteins discussed in the review, classified by the developmental process that
regulate, binding partner and mechanism of action. Domain abbreviations are: Ig, Ig-like domain; LRR, Leucine-rich repeat domain; LRR-NT and LRR-CT, LRR N-
and C-terminal domain; CRD, cysteine-rich domain; PDZ, PSD-95/disk-large/zona-occludens-1 domain; TKD, Tyrosine-kinase domain.
LRR PROTEINS IN THE CONTROL OF
AXONAL GROWTH AND GUIDANCE
During the establishment of neuronal circuits, neurons extend
axons that navigate over long distances toward their target
regions. Along their trajectories, growth cones are guided by
the coordinated action of attractive and repulsive cues localized
in the extracellular environment. Many evidences indicate
that during embryonic development, LRR proteins provide
instructive and modulatory signals for axonal navigation, and in
this section we discuss the role of LRR proteins in axonal growth,
guidance and target innervation.
Trk neurotrophin receptors are a family of LRR proteins that
not only promote axonal growth but also have chemotactive
effects in the steering direction of growing axons. Various
genetically modified mouse models have provided a better
understanding of the roles of neurotrophin/Trk signaling in the
establishment of neuronal connectivity in the peripheral nervous
system. Primary somatosensory neurons located in the dorsal
root ganglia (DRG) send axons to the periphery to innervate the
skin and muscles, and project central axons to the second-order
neurons in the spinal cord. Evidence from different subtypes
of somatosensory neurons has revealed a common requirement
of target-derived neurotrophins during projection of sensory
axons toward their respective central and peripheral targets.
Thus, TrkA expressed in cutaneous nociceptive sensory neurons
is required for nociceptor innervation of the skin and for the
generation of proper axonal projections in the spinal cord (Patel
et al., 2003; Guo et al., 2011), and many cutaneous TrkB-
positive low-threshold mechanoreceptors require BDNF/TrkB
signaling for correct axonal innervation of several types of
cutaneous mechanosensory end organs (Perez-Pinera et al.,
2008).
In addition to their roles in the peripheral sensory system,
Trk receptor signaling is also essential for axonal growth,
target innervation and survival of postganglionic sympathetic
neurons. Here, intermediate target-derived NT3 (e.g., blood
vessels) acts via TrkA to support axonal extension, but not
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retrograde survival, whereas NGF produced from final targets
(e.g., heart) supports not only axonal growth but also survival and
gene expression through retrograde signaling. Interestingly, these
studies illustrate a model in which a hierarchical neurotrophin
signaling cascade coordinates the specificity of sympathetic
neuronal innervation (Glebova and Ginty, 2004; Kuruvilla et al.,
2004).
Interestingly, in Drosophila, there are no canonical homologs
of Trk receptors, but two recent studies indicated that the Toll-
LRR proteins fulfill this function. In flies, Toll6 and Toll7 have
been described as new neurotrophin receptors involved in the
control of motor axon targeting and neuronal survival (Lewis
et al., 2013; McIlroy et al., 2013). Thus, it will be interesting to
study whether the neurotrophins and Toll-like receptor (TLR)
protein families interact to control neuronal connectivity also in
the vertebrate nervous system.
Several truncated isoforms of TrkB and TrkC, which lack
most of the intracellular domain (ICD) have been identified
(Reichardt, 2006). Truncated TrkB receptors (TrkB.T1 and
TrkB.T2) are splice variants having short cytoplasmic tails
lacking the tyrosine kinase domain and are expressed at
high levels in the adult brain (Reichardt, 2006). The precise
physiological function of these receptors is not completely
known, but they seem to act as dominant negative modulators
of Trk signaling, capturing neurotrophins, blocking activation of
full-length Trk kinases by forming nonproductive heterodimers
or even mediating autonomous signaling events directly (Baxter
et al., 1997; Hapner et al., 1998; Kryl and Barker, 2000;
Esteban et al., 2006). TrkB.T1 is considered the prototype
of truncated TrkB receptors. In an effort to understand how
the TrkB.T1 receptors contribute to the establishment and
development of neural circuits, Liu et al. (2012) demonstrated
that androgen-driven expression of the truncated TrkB.T1 in
male mammarymesenchyme is required for inhibition of BDNF-
induced TrkB signaling in sensory axons. This inhibition of
BDNF/TrkB signaling in sensory fibers leads to axonal pruning
and generation of the male-type pattern of mammary gland
sensory innervation. Therefore, truncated TrkB.T1 receptors
direct the sexually dimorphic control of BDNF signaling that
determines sensory innervation of themammary gland (Liu et al.,
2012).
Besides having LRR domains, Trk receptors are able to
interact with other LRR-containing proteins. Recent data suggest
that neurotrophic factor receptors, Trks and Ret physically
associate with diverse LRR-containing proteins to modulate their
signaling outputs (Ledda et al., 2008; Mandai et al., 2009; Meabon
et al., 2015; Song et al., 2015; Alsina et al., 2016).
Linx (alias Islr2) is a LRR transmembrane protein that was
identified as a TrkA and Ret signaling component (Mandai
et al., 2009). Linx is coexpressed with TrkA and Ret receptors
in many developing sensory nociceptive and motor neurons,
respectively. Linx interacts with TrkA and Ret receptors and
facilitates their activities of axonal growth, guidance and
branching. In addition to Linx, several other LRR family
members, including Lrig1, Lingo1 and Amigo, are expressed
in non-overlapping subset of sensory and motor neurons. This
raises the possibility that different LRR proteins encode target
specificity by controlling the activity of neurotrophic receptors
in select populations of developing neurons (Mandai et al.,
2009).
Linx was later described as a key interaxonal signal that guides
the extension of central axons independently of its interaction
with neurotrophic factor receptors. Linx induces the outgrowth
of thalamocortical axons in the ventral forebrain, and mediates
thalamortical and corticofugal close interactions at the pallial-
subpallial boundary. In this system, Linx do not interact with
neurotrophic factor receptors and might cooperatively function
with diverse thalamic axon guidance cues, such as slits, netrin-1,
neuregulin-1, ephrins, EphB1/2, Sema 3A and Sema 3F (Mandai
et al., 2014).
Furthermore, a new role of Linx in ensuring proper retinal
axon navigation at the vertebrate optic chiasm has recently been
reported (Panza et al., 2015). However, whether the guidance
effects of Linx in this system are uncoupled from its neurotrophic
function deserves additional investigation.
The LRR and Ig-like domain protein 1 (Lrig1) is another
protein that was described as a neurotrophic factor receptor
interactor. This molecule belongs to the Lrig family of single-pass
transmembrane proteins, which modulate a variety of signaling
pathways across evolution. In vertebrates, there are three family
members, (Lrig1, Lrig2, and Lrig3), which are defined by closely
related extracellular domains with a similar arrangement of
15 LRRs and three Ig-like domains and a cytoplasmic region
with no apparent homology to other proteins. Lrig1 is the
best functionally-characterized member of the family, which
controls the activity of different growth factor RTKs, such as
EGFR, ErbB 2–4 and Met, by promoting receptor ubiquitination
and degradation (Gur et al., 2004; Laederich et al., 2004;
Shattuck et al., 2007; Simion et al., 2014). In 2008, Lrig1 was
reported as an endogenous inhibitor of the GDNF receptor
Ret (Ledda et al., 2008), able to block GDNF/Ret-induced
axonal growth of sympathetic neurons. From a mechanistic
point of view, Lrig1 directly interacts with Ret and negatively
regulates GDNF/Ret signaling through inhibition of GDNF
binding to Ret and recruitment of Ret to lipid raft membrane
domains. Despite this, the physiological contribution of Lrig1
for GDNF/Ret-induced axonal growth and peripheral target
innervation require additional studies. It is unclear whether
Lrig2 and Lrig3 exhibit similar functions to Lrig1 in this
system.
Although nothing is known about the role of Lrig2 and Lrig3
on the control of neurotrophic factor receptor signaling, Lrig2
was recently identified as a regulator of axon guidance activities
in central neurons. Neural circuit development also requires
the precise regulation of guidance receptors at the plasma
membrane. Different mechanisms control guidance receptor
expression and function at the plasma membrane, including
proteolysis by membrane-bound ADAM proteases (Bai and
Pfaff, 2011; Kolodkin and Pasterkamp, 2013). Previous work
implicated ADAM17 (TACE) in repulsive guidance molecule
family member A (RGMa)-Neogenin signaling by showing that
this protease cleaves the Neogenin ectodomain in cis and
thereby terminates, rather than activates, repulsive Neogenin
signaling (Okamura et al., 2011). Ectodomain shedding is
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crucial for receptor signaling and function, but how this
event is regulated in developing neurons has begun to be
elucidated. Recent data demonstrated that Lrig2 negatively
regulates ectodomain shedding of axon guidance receptors by
ADAM17. Lrig2 binds Neogenin, a receptor for RGMs, and
prevents premature Neogenin cleavage by ADAM17. RGMa
ligands reduce Lrig2-Neogenin complexes, providing ADAM17
access to Neogenin and allowing this protease to induce
ectodomain shedding. This regulatory mechanism is required
for both the growth cone collapse and the axonal growth
inhibitory effects of RGMa-Neogenin signaling (van Erp et al.,
2015). Thus, strategies directed to knockdown Lrig2 significantly
improved CNS axon regeneration, and identified Lrig2 as
a potential therapeutic target for promoting regeneration of
injured axons.
Interestingly, it has been reported that mutations in Lrig2
cause urofacial syndrome (UFS), an autosomal-recessive
disease characterized by congenital urinary bladder dysfunction
associated with a significant risk of kidney failure and abnormal
facial expression. Although the mechanism underlying
this effect is still unknown, the evidence indicates that
Lrig2 is required for normal autonomic innervation of the
urinary tract (Stuart et al., 2013; Woolf et al., 2014). In
addition to this effect of Lrig2, sensory innervation of the
cochlea has been observed to be disrupted in Lrig1:Lrig2
double-mutant mice, indicating that Lrig1 and Lrig2 exert
complementary functions during inner ear innervation.
Together these findings uncover novel roles of Lrig2 in the
peripheral nervous system, perhaps functioning as modulators
of neurotrophic factor signaling pathways (Del Rio et al.,
2013).
The Slitrk family includes six brain-specific transmembrane
proteins (Slitrk1–6) that contain extracellular LRR domains
homologous to the axon guidance molecule Slit and intracellular
C-terminal tyrosine residues with sequences homologous to
the Trk molecules. In particular, Slitrk6 promotes the survival
and innervation of sensory neurons in the inner ear, at least
in part by modulating neurotrophin–Trk receptor signaling.
Interestinlgy, BDNF and NT3 mRNA levels, as well as their
cognate receptors TrkB and TrkC, were downregulated in the
inner ear of Slitrk6-knockout mice, indicating that Slitrk6 acts as
a positive regulator of TrkB and TrkC signaling (Katayama et al.,
2009).
Lingo1 is a transmembrane LRR protein that has been
reported to influence axonal growth through two different
mechanisms, one involving its interaction with p75NTR and
other partnering with Trk neurotrophin receptors (Mi et al.,
2004; Meabon et al., 2015). Initially, Lingo1 was identified as a
crucial component of the p75NTR/NgR1 (Nogo receptor, a GPI-
anchored LRR protein) complex mediating axonal growth cone
collapse (Mi et al., 2004). Axonal regeneration in the injured
adult CNS is inhibited by myelin-derived inhibitory molecules
(Nogo, MAG and OMgp), which bind to NgR1 and trigger
growth cone collapse through the Rho GTPase pathway by
associating with the two transmembrane co-receptors p75NTR
and Lingo1 (Wang et al., 2002; Filbin, 2003; Mi et al., 2004).
More recent findings indicate a novel role for Lingo1 in the
modulation of Trk RTK activity (Fu et al., 2010; Meabon
et al., 2015). Here, the suggested model indicates that Lingo1
encounters activated Trk receptors in endosomes and this
interaction leads Trks away from the recycling pathway and
directs them into endolysosomal pathway for its degradation.
Thus, Lingo1 acts as a negative regulator of Trk neurotrophin
receptor signaling.
A recent study showed that another member of the
superfamily of LRR-containing proteins, Amphoterin-induced
gene and open reading frame 3 (Amigo3), represents a novel
and alternative p75NTR/NgR co-receptor that mediates myelin-
associated axonal growth inhibition in the acute phase of adult
CNS injury (Ahmed et al., 2013). Thus, blocking Amigo3
immediately after CNS injury might provide a very effective
therapeutic strategy for promoting axon regeneration when
combined with neurotrophic factor administration. Amigo3
belongs to a family of transmembrane proteins with six LRR
motives and a single Ig-like domain, which includes two
other members. The expression of Amigo members is enriched
in the nervous system. The three members of the Amigo
family exhibit both homophilic and heterophilic binding activity
that may facilitate neuronal growth functioning as adhesion
molecules.
LRR PROTEINS IN THE CONTROL OF
DENDRITIC GROWTH AND MORPHOLOGY
Dendrite size and morphology are key determinants of the
functional properties of neurons, and many neurodevelopmental
and psychiatric disorders are due primarily to structural
abnormalities of dendrites and their connections (Kulkarni and
Firestein, 2012). Neurotrophin signaling through Trk receptors
is one of the most studied molecular complexes that promote
growth, branching and spine density of developing dendrites
in different brain areas (McAllister et al., 1995; Imamura
and Greer, 2009; Kwon et al., 2011; Lazo et al., 2013; Joo
et al., 2014). In particular, BDNF and its receptor TrkB have
been described to be required for dendritic growth and spine
formation in different brain regions including the cortex,
hippocampus and striatum. Target deletion of BDNF in mice
from excitatory CNS neurons resulted in deficits in dendritic
growth and spine density in different brain regions (Rauskolb
et al., 2010).
Moreover, NT4 has also been described as a dendritogenic
factor for cortical pyramidal cells and interneurons (Wirth
et al., 2003). Recent studies revealed that NT3/TrkC signaling
modulates dendritic complexity of Purkinje cerebellar neurons
in vivo (Joo et al., 2014). Intriguingly, the authors described
that TrkC-deficient Purkinje neurons have reduced complexity,
which is rescued by removal of NT3.
Although neurotrophins and their receptors have essential
roles in dendrite patterning, how a limited repertoire of
neurotrophins and Trk receptors promote a diverse array
of dendritic patterns is a question that has recently begun
to be answered. In this sense, recent studies have identified
key cell-intrinsic regulators of the diverse array of dendrite
morphologies promoted by neurotrophins in the CNS. In
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one of these studies, Slitrk5 has been identified as a novel
TrkB receptor interactor. Although all members of Slitrk
family expressed in the postsynaptic compartment induce
presynaptic differentiation by trans-synaptic interaction
with Protein Tyrosine Phosphatases (PRPs) located in the
presynaptic side, Slitrk5 has emerged as a TrkB receptor
component that facilitates BDNF-induced TrkB signaling
required to dendrite morphogenesis of striatal GABAergic
neurons. Upon BDNF stimulation, Slitrk5 forms a physical
complex with TrkB through their LRR domains and directs TrkB
receptor to Rab11-positive recycling endosomes promoting
neurotrophin signaling. In this context, Slitrk5-null mice
exhibit reduced striatal volume, decreased dendrite complexity
and affected basal ganglia circuitry and function, similar
to the phenotype reported in the striatum of mice with
genetic deficiencies in BDNF and TrkB signaling (Song et al.,
2015).
Recently, the nervous system-enriched LRR protein Lrig1 was
identified as a physiological regulator of proximal hippocampal
dendrite arborization and BDNF signaling. Lrig1-deficient
animals show an increase in primary dendrite formation and
dendritic branching of hippocampal pyramidal neurons, two
phenotypes that resemble the effect of BDNF on these neurons.
In addition to restrict dendrite morphogenesis, overexpression
of Lrig1 also blocked the formation of dendritic spines
induced by BDNF in these neurons. Despite this, the exact
mechanism through which Lrig1 controls BDNF signaling is
not completely known, a physical interaction between TrkB
and Lrig1 seems to be required to inhibit receptor activation
and BDNF signaling (Alsina et al., 2016). During development,
different neuronal domains encounter similar environmental
factors. However, intrinsic modulators, located within specific
domains of the neurons, control the cellular interpretation
of these extrinsic cues, thereby allowing neurons to generate
distinct morphologies. Interestingly, Lrig1 is located in the
soma and extends out into the apical dendrites of hippocampal
pyramidal neurons, controlling BDNF signaling in this neuronal
domain. In agreement with this, ablation of Lrig1 preferentially
increases the proximal complexity of the apical dendrites of
hippocampal CA1–CA3 pyramidal neurons, revealing a novel
molecular mechanism involved in basal vs. apical dendrite
morphogenesis.
Together, these findings establish that Slitrk5 and Lrig1
are essential molecules linking TrkB signaling to dendrite
development in different brain areas.
LRR PROTEINS AND DISORDERS OF THE
NERVOUS SYSTEM
Given the critical role played by genes encoding LRR proteins
in the organization and function of neural circuits, it seems
likely that mutations in genes encoding LRR proteins or in their
binding partners could compromise axon guidance, dendrite
arborization, synapse development and lead to a range of
neurodevelopmental and psychiatric disorders. LRR proteins
have been directly linked to different human brain disorders,
including autism, schizophrenia, obsessive-compulsive disorders
(OCD), epilepsy, essential tremor (ET), Alzheimer’s (AD) and
Parkinson’s disease (PD; de Wit et al., 2011; Ko, 2012; see
Table 1). Here, we focus on those LRR proteins that modulate
signaling by neurotrophic factors and that are discussed in this
review.
Considering the significant heritability of many
neurodevelopmental and psychiatric disorders, recent efforts
have focused on the search for susceptibility genes for these
diseases. A recent study has revealed that Slitrk5-deficient
mice show increased anxiety-like and excessive self-grooming
behaviors, characteristic of obsessive-compulsive-like behavior
(Shmelkov et al., 2010). Treatment with chronic fluoxetine, a
selective serotonin reuptake inhibitor used to treat depression
and OCD, alleviated the excessive grooming behavior observed
in Sllitrk5 null mice. Further analysis of Slitrk5 knockout mice
indicates that corticostriatal circuitry, which is implicated in
the pathogenesis of OCD, is specifically affected by deletion of
Slitrk5. Moreover, Slitrk5 deficiency reduces dendrite complexity
of striatal medium spiny neurons and impairs corticostriatal
TABLE 1 | Leucine-rich repeat (LRR) proteins implicated in neurodegenerative, neurodevelopmental and psychiatric disorders.
LRR proteins Behavioral defects/Disorder Reference
TrkA Congenital insensitivity to pain with anhidrosis (CIPA) Indo (2014)
Schizophrenia Van Schijndel et al. (2011)
TrkB Alzheimer’s disease Chen et al. (2008)
Autism spectrum disorder (ASD) Chandley et al. (2015)
Huntington’s disease Plotkin et al. (2014) and Nguyen et al. (2016)
Bipolar disease Dmitrzak-Weglarz et al. (2008)
Schizophrenia and mood disorders Ray et al. (2011, 2014)
Epilepsy Liu et al. (2013)
Lingo1 Parkinson’s disease and essential tremor Inoue et al. (2007), Kuo et al. (2013) and Delay et al. (2014)
Glaucoma Fu et al. (2008, 2010)
Schizophrenia Fernandez-Enright et al. (2014)
Lrig1 Abnormal social interaction Alsina et al. (2016)
Lrig2 Urofacial syndrome (UFS)/congenital urinary bladder Stuart et al. (2013) and Woolf et al. (2014)
Slitrk1 Tourette’s syndrome Abelson et al. (2005)
Slitrk5 Obsessive-compulsive disorder (OCD). Anxiety Shmelkov et al. (2010)
The table includes those LRR proteins covered in this review. Some behavioral phenotypes obtained in deficient mice are also mentioned.
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neurotransmission, an effect that may be due to lower expression
of glutamate receptors in the striatum (Shmelkov et al., 2010).
Together this genetic evidence clearly supports a role of Slitrk5
for the development of the neural circuits associated with anxiety
disorders and establishes a new mouse model of OCD-like
behaviors. Interestingly, Slitrk1-deficient mice also display
elevated anxiety-like behavior characteristics of OCD (Katayama
et al., 2010). Moreover, Slitrk1 has also been identified as a
candidate gene for Tourette’s syndrome (TS), a psychiatric
disorder characterized by involuntary physical and vocal tics
(Abelson et al., 2005).
Mental retardation and autism spectrum disorders are genetic
diseases often associated with overgrowth or lack of dendrite
pruning during development and characterized by impaired
sociability and altered social phenotypes. Recently, it was
reported that Lrig1-deficient mice exhibit hippocampal dendritic
abnormalities that correlate with deficits in social interaction
(Alsina et al., 2016). Intriguingly, these findings raise the
possibility that Lrig1 dysfunction may contribute to different
cognitive and developmental brain disorders.
Several studies revealed detrimental roles of Lingo1 during
nervous system development (Mi et al., 2009; Andrews and
Fernandez-Enright, 2015). Lingo1 was first implicated in PD,
when it was discovered that Lingo1 is upregulated in the
substantia nigra of post mortem PD brains and in animal models
of PD after neurotoxic lesions of the midbrain dopaminergic
neurons (Inoue et al., 2007). In one of these studies, Inoue et al.
(2007) demonstrated that Lingo1 antagonists improve dopamine
neuron survival, growth, and function using in vivo models of
PD. This neuroprotective effect involves the activation of the
EGFR/PI3K/Akt signaling pathway through a direct inhibition of
Lingo1’s binding to the EGFR (Inoue et al., 2007).
ET is the most prevalent adult-onset movement disorder.
Higher levels of Lingo1 protein have been detected in cerebellum
of ET patients (Kuo et al., 2013; Delay et al., 2014). It is
hypothesized that these changes are due to post-transcriptional
alterations, because not mRNA alterations were detected.
Therefore, the downregulation of Lingo1 in the cerebellum is a
potential disease-modifying therapeutic target for this pathology.
In agreement with this, Lingo1 has already received attention
concerning its potential as drug target of interest for treatment
of PD (Inoue et al., 2007), and other pathologies of the nervous
system (Ji et al., 2006; Satoh et al., 2007).
Glaucoma is another neurodegenerative disease characterized
by abnormally high intraocular pressure and blindness due to
retinal ganglion cell (RGC) death. Both Lingo1 and NgR were
found to be upregulated in RGCs in an ocular hypertension
paradigm in rats (Fu et al., 2008, 2010). Blocking Lingo1
function, either using Lingo1-Fc or antibodies against Lingo1,
has been shown to not only reduce the number of RGCs
that were lost after ocular hypertension, but also promote
the survival of RGCs following optic nerve injury (Fu et al.,
2008, 2010). The mechanism through which Lingo1 inhibitors
induce neuroprotection involves the RhoA and PI3K/Akt
signaling pathways. Lingo1 is able to form a complex with
TrkB following ocular hypertension, and it was observed that
Lingo1 antagonists caused higher TrkB activation than BDNF
alone, leading to the survival of RGCs (Fu et al., 2009,
2010).
Recently, Fernandez-Enright et al. (2014) have provided the
first evidence of an implication of Lingo1 in schizophrenia, by
observing alterations in the expression profiles of Lingo1 and
their signaling partner proteins in the dorsolateral prefrontal
cortex and CA1–CA3 hippocampal areas of post-mortem
schizophrenia brains, two regions highly disrupted in this
pathology.
Finally, altered BDNF/TrkB signaling has been implicated
in the pathophysiology of neurodegenerative and psychiatric
disorders including, AD, PD, HD, bipolar disease and epilepsy
(Chen et al., 2008; Dmitrzak-Weglarz et al., 2008; Gupta et al.,
2013; Liu et al., 2013; Plotkin et al., 2014; Chandley et al.,
2015; Mariga et al., 2016; Nguyen et al., 2016). Levels of TrkB
mRNA were reported to decrease in the hippocampus of patients
suffering from schizophrenia and/or mood disorders (Ray et al.,
2011, 2014) and TrkA polymorphism has also been associated
with schizophrenia (Van Schijndel et al., 2011). Considering the
regulatory role of different LRR proteins on Trk signaling, it
becomes important to understand the role of these modulators in
the neurodegenerative and psychiatric disorders associated with
neurotrophins and Trks.
Finally, genetic evidence also links some LRR proteins with
congenital disorders of the nervous system. Thus, Lrig2 has
been associated with congenital urinary bladder dysfunction, a
disease characterized by abnormal innervation of the urinary
tract (Stuart et al., 2013; Woolf et al., 2014). In addition, loss of
functionmutations in TrkA have been associated with congenital
insentivity to pain with anhidrosis (CIPA), an autosomal
genetic disorder characterized by the absence of NGF-dependent
primary afferent fibers and sympathetic postganglionic neurons
(Indo, 2014).
Thus, the modulation of neurotrophic factor receptor
signaling represents a powerful therapeutic approach
for reversing neuronal dysfunctions associated with
neurodegenerative, neurodevelopmental and psychiatric
disorders.
CONCLUDING REMARKS
More than 20 years after the discovery of neurotrophic
factor receptors, recent findings continue providing novel
receptor modulators/components capable to execute complex
regulatory mechanisms of receptor signaling that diversify
neurotrophic function. These studies establish that engagement
of neurotrophic receptors with specific LRR proteins represents
a general mechanism that explains how neurons within a
particular region of the nervous system expand the repertoire
of neurotrophic factor signaling outputs during circuit
development. We are now beginning at understanding the
mechanistic details through which LRR proteins regulate
guidance/neurotrophic factor receptor signaling. The evidence
obtained so far indicate that these proteins can modulate
receptor activity in opposite ways, inhibiting or promoting
receptor activation through different mechanisms such as ligand
binding, receptor ubiquitination, shedding, and trafficking
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(Ledda et al., 2008; Simion et al., 2014; Meabon et al., 2015; Song
et al., 2015; van Erp et al., 2015).
Many LRR proteins have multiple binding partners across
the synapses, in trans, and as neurotrophin receptor interactors
functioning in cis. Despite these advances, several key questions
remain unanswered. For instance, it will be important to fully
characterize these protein interaction networks, identify the
molecular domains that govern these interactions, and determine
the physiological contribution of these proteins for nervous
system development and function.
Although several questions remain to be addressed, an
increased understanding of the roles of LRR proteins promises to
give insights into the many neurodevelopmental and psychiatric
disorders typified by alterations in neural circuitry, and may aid
to achieve effective therapies to cure these neurological diseases.
Neurotrophic factors have emerged as promising disease-
modifying molecules for neurological disorders and regeneration
of damaged axons, and some of them are currently being used
in clinical trials. However, they had limited success in the
treatment of neurodegenerative diseases due to pharmacokinetic
and delivery issues. It appears likely that many of these LRR
proteins represent new potential therapeutic targets for these
disorders. Thus, targeting endogenous regulators/components of
neurotrophic factor receptor signaling, such as Lrig1, Slitrk5,
Lingo1 and Amigo3, might be of clinical interest, maximizing the
therapeutic power of neurotrophic factors on injured neurons in
a region-specific manner.
AUTHOR CONTRIBUTIONS
FL and GP wrote the manuscript.
ACKNOWLEDGMENTS
Work in the author’s laboratory is funded by grants for the
Argentine Agency for Promotion of Science and Technology
(ANPCyT) PICT2013-0914, PICT2014-2155 andUBACyT 2013-
2016GC (20020120100026BA). FL and GP are supported by
an independent research career position from the Argentine
Medical Research Council (CONICET), Argentina.
REFERENCES
Abelson, J. F., Kwan, K. Y., O’Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan,
T.M., et al. (2005). Sequence variants in SLITRK1 are associated with Tourette’s
syndrome. Science 310, 317–320. doi: 10.1126/science.1116502
Ahmed, Z., Douglas, M. R., John, G., Berry, M., and Logan, A. (2013). AMIGO3
is an NgR1/p75 co-receptor signalling axon growth inhibition in the acute
phase of adult central nervous system injury. PLoS One 8:e61878. doi: 10.
1371/journal.pone.0061878
Alsina, F. C., Hita, F. J., Fontanet, P. A., Irala, D., Hedman, H., Ledda, F., et al.
(2016). Lrig1 is a cell-intrinsic modulator of hippocampal dendrite complexity
and BDNF signaling. EMBO Rep. 17, 601–616. doi: 10.15252/embr.201541218
Andrews, J. L., and Fernandez-Enright, F. (2015). A decade from discovery
to therapy: Lingo-1, the dark horse in neurological and psychiatric
disorders. Neurosci. Biobehav. Rev. 56, 97–114. doi: 10.1016/j.neubiorev.2015.
06.009
Bai, G., and Pfaff, S. L. (2011). Protease regulation: the Yin and Yang of neural
development and disease. Neuron 72, 9–21. doi: 10.1016/j.neuron.2011.09.012
Baxter, G. T., Radeke, M. J., Kuo, R. C., Makrides, V., Hinkle, B., Hoang, R., et al.
(1997). Signal transduction mediated by the truncated trkB receptor isoforms,
trkB.T1 and trkB.T2. J. Neurosci. 17, 2683–2690.
Björklund, A. K., Ekman, D., and Elofsson, A. (2006). Expansion of protein
domain repeats. PLoS Comput. Biol. 2:e114. doi: 10.1371/journal.pcbi.0020114
Bothwell, M. (2014). NGF, BDNF, NT3 and NT4. Handb. Exp. Pharmacol. 220,
3–15. doi: 10.1007/978-3-642-45106-5_1
Chandley, M. J., Crawford, J. D., Szebeni, A., Szebeni, K., and Ordway, G. A.
(2015). NTRK2 expression levels are reduced in laser captured pyramidal
neurons from the anterior cingulate cortex in males with autism spectrum
disorder.Mol. Autism 6:28. doi: 10.1186/s13229-015-0023-2
Chen, Y., Aulia, S., Li, L., and Tang, B. L. (2006). AMIGO and friends: an
emerging family of brain-enriched, neuronal growth modulating, type I
transmembrane proteins with leucine-rich repeats (LRR) and cell adhesion
molecule motifs. Brain Res. Rev. 51, 265–274. doi: 10.1016/j.brainresrev.2005.
11.005
Chen, Z., Simmons, M. S., Perry, R. T., Wiener, H. W., Harrell, L. E., and Go,
R. C. (2008). Genetic association of neurotrophic tyrosine kinase receptor type
2 (NTRK2) with Alzheimer’s disease. Am. J. Med. Genet. B Neuropsychiatr.
Genet. 147, 363–369. doi: 10.1002/ajmg.b.30607
de Wit, J., and Ghosh, A. (2014). Control of neural circuit formation by leucine-
rich repeat proteins. Trends Neurosci. 37, 539–550. doi: 10.1016/j.tins.2014.
07.004
de Wit, J., Hong, W., Luo, L., and Ghosh, A. (2011). Role of leucine-
rich repeat proteins in the development and function of neural circuits.
Annu. Rev. Cell Dev. Biol. 27, 697–729. doi: 10.1146/annurev-cellbio-092910-
154111
Delay, C., Tremblay, C., Brochu, E., Paris-Robidas, S., Emond, V., Rajput, A. H.,
et al. (2014). Increased LINGO1 in the cerebellum of essential tremor patients.
Mov. Disord. 29, 1637–1647. doi: 10.1002/mds.25819
Del Rio, T., Nishitani, A. M., Yu, W. M., and Goodrich, L. V. (2013). In vivo
analysis of Lrig genes reveals redundant and independent functions in the inner
ear. PLoS Genet. 9:e1003824. doi: 10.1371/journal.pgen.1003824
Dmitrzak-Weglarz, M., Rybakowski, J. K., Suwalska, A., Skibinska, M.,
Leszczynska-Rodziewicz, A., Szczepankiewicz, A., et al. (2008). Association
studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic
lithium response in bipolar patients. Pharmacogenomics 9, 1595–1603. doi: 10.
2217/14622416.9.11.1595
Dolan, J., Walshe, K., Alsbury, S., Hokamp, K., O’Keeffe, S., Okafuji, T., et al.
(2007). The extracellular leucine-rich repeat superfamily; a comparative survey
and analysis of evolutionary relationships and expression patterns. BMC
Genomics 8:320. doi: 10.1186/1471-2164-8-320
Esteban, P. F., Yoon, H. Y., Becker, J., Dorsey, S. G., Caprari, P., Palko, M. E., et al.
(2006). A kinase-deficient TrkC receptor isoform activates Arf6-Rac1 signaling
through the scaffold protein tamalin. J. Cell Biol. 173, 291–299. doi: 10.1083/jcb.
200512013
Fernandez-Enright, F., Andrews, J. L., Newell, K. A., Pantelis, C., and
Huang, X. F. (2014). Novel implications of Lingo-1 and its signaling
partners in schizophrenia. Transl. Psychiatry 4:e348. doi: 10.1038/tp.
2013.121
Filbin, M. T. (2003). Myelin-associated inhibitors of axonal regeneration in the
adult mammalian CNS. Nat. Rev. Neurosci. 4, 703–713. doi: 10.1038/nrn1195
Fu, Q. L., Hu, B., Li, X., Shao, Z., Shi, J. B., Wu, W., et al. (2010). LINGO-1
negatively regulates TrkB phosphorylation after ocular hypertension. Eur. J.
Neurosci. 31, 1091–1097. doi: 10.1111/j.1460-9568.2010.07127.x
Fu, Q. L., Hu, B., Wu, W., Pepinsky, R. B., Mi, S., and So, K. F. (2008). Blocking
LINGO-1 function promotes retinal ganglion cell survival following ocular
hypertension and optic nerve transection. Invest. Ophthalmol. Vis. Sci. 49,
975–985. doi: 10.1167/iovs.07-1199
Fu, Q. L., Li, X., Yip, H. K., Shao, Z., Wu, W., Mi, S., et al. (2009).
Combined effect of brain-derived neurotrophic factor and LINGO-1
fusion protein on long-term survival of retinal ganglion cells in chronic
glaucoma. Neuroscience 162, 375–382. doi: 10.1016/j.neuroscience.2009.
04.075
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 August 2016 | Volume 10 | Article 199
Ledda and Paratcha Neurotrophic Signaling Modulation by LRR Proteins
Garcès, A., Haase, G., Airaksinen, M. S., Livet, J., Filippi, P., and deLapeyrière,
O. (2000). GFRα 1 is required for development of distinct subpopulations of
motoneuron. J. Neurosci. 20, 4992–5000.
Glebova, N. O., and Ginty, D. D. (2004). Heterogeneous requirement of NGF
for sympathetic target innervation in vivo. J. Neurosci. 24, 743–751. doi: 10.
1523/jneurosci.4523-03.2004
Guo, T., Mandai, K., Condie, B. G., Wickramasinghe, S. R., Capecchi, M. R., and
Ginty, D. D. (2011). An evolving NGF-Hoxd1 signaling pathway mediates
development of divergent neural circuits in vertebrates. Nat. Neurosci. 14,
31–36. doi: 10.1038/nn.2710
Gupta, V. K., You, Y., Gupta, V. B., Klistorner, A., and Graham, S. L. (2013).
TrkB receptor signalling: implications in neurodegenerative, psychiatric
and proliferative disorders. Int. J. Mol. Sci. 14, 10122–10142. doi: 10.
3390/ijms140510122
Gur, G., Rubin, C., Katz, M., Amit, I., Citri, A., Nilsson, J., et al. (2004). LRIG1
restricts growth factor signaling by enhancing receptor ubiquitylation and
degradation. EMBO J. 23, 3270–3281. doi: 10.1038/sj.emboj.7600342
Hahn, M., and Bishop, J. (2001). Expression pattern of Drosophila ret suggests
a common ancestral origin between the metamorphosis precursors in insect
endoderm and the vertebrate enteric neurons. Proc. Natl. Acad. Sci. U S A 98,
1053–1058. doi: 10.1073/pnas.021558598
Hapner, S. J., Boeshore, K. L., Large, T. H., and Lefcort, F. (1998). Neural
differentiation promoted by truncated trkC receptors in collaboration with
p75NTR. Dev. Biol. 201, 90–100. doi: 10.1006/dbio.1998.8970
Hempstead, B. L. (2014). Deciphering proneurotrophin actions. Handb. Exp.
Pharmacol. 220, 17–32. doi: 10.1007/978-3-642-45106-5_2
Ibañez, C. F., and Andressoo, J. O. (2016). Biology of GDNF and its
receptors—relevance for disorders of the central nervous system. Neurobiol.
Dis. doi: 10.1016/j.nbd.2016.01.021 [Epub ahead of print].
Imamura, F., and Greer, C. A. (2009). Dendritic branching of olfactory bulb mitral
and tufted cells: regulation by TrkB. PLoS One 4:e6729. doi: 10.1371/journal.
pone.0006729
Indo, Y. (2014). Neurobiology of pain, interoception and emotional response:
lessons from nerve growth factor-dependent neurons. Eur. J. Neurosci. 39,
375–391. doi: 10.1111/ejn.12448
Inoue, H., Lin, L., Lee, X., Shao, Z., Mendes, S., Snodgrass-Belt, P., et al. (2007).
Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival,
structure and function of dopaminergic neurons in Parkinson’s disease models.
Proc. Natl. Acad. Sci. U S A 104, 14430–14435. doi: 10.1073/pnas.0700901104
Ji, B., Li, M., Wu, W. T., Yick, L. W., Lee, X., Shao, Z., et al. (2006). LINGO-1
antagonist promotes functional recovery and axonal sprouting after spinal cord
injury.Mol. Cell. Neurosci. 33, 311–320. doi: 10.1016/j.mcn.2006.08.003
Joo, W., Hippenmeyer, S., and Luo, L. (2014). Neurodevelopment. Dendrite
morphogenesis depends on relative levels of NT-3/TrkC signaling. Science 346,
626–629. doi: 10.1126/science.1258996
Katayama, K., Yamada, K., Ornthanalai, V. G., Inoue, T., Ota, M., Murphy, N. P.,
et al. (2010). Slitrk1-deficient mice display elevated anxiety-like behavior and
noradrenergic abnormalities. Mol. Psychiatry 15, 177–184. doi: 10.1038/mp.
2008.97
Katayama, K., Zine, A., Ota,M.,Matsumoto, Y., Inoue, T., Fritzsch, B., et al. (2009).
Disorganized innervation and neuronal loss in the inner ear of Slitrk6-deficient
mice. PLoS One 4:e7786. doi: 10.1371/journal.pone.0007786
Ko, J. (2012). The leucine-rich repeat superfamily of synaptic adhesion molecules:
LRRTMs and Slitrks.Mol. Cells 34, 335–340. doi: 10.1007/s10059-012-0113-3
Kobe, B., and Kajava, A. V. (2001). The leucine-rich repeat as a protein recognition
motif. Curr. Opin. Struct. Biol. 11, 725–732. doi: 10.1016/s0959-440x(01)
00266-4
Kolodkin, A. L., and Pasterkamp, R. J. (2013). SnapShot: axon guidance II. Cell
153:722.e1. doi: 10.1016/j.cell.2013.04.004
Kramer, E. R., Knott, L., Su, F., Dessaud, E., Krull, C. E., Helmbacher, F.,
et al. (2006). Cooperation between GDNF/Ret and ephrinA/EphA4 signals for
motor-axon pathway selection in the limb. Neuron 50, 35–47. doi: 10.1016/j.
neuron.2006.02.020
Kryl, D., and Barker, P. A. (2000). TTIP is a novel protein that interacts with the
truncated T1 TrkB neurotrophin receptor. Biochem. Biophys. Res. Commun.
279, 925–930. doi: 10.1006/bbrc.2000.4058
Kulkarni, V. A., and Firestein, B. L. (2012). The dendritic tree and brain disorders.
Mol. Cell. Neurosci. 50, 10–20. doi: 10.1016/j.mcn.2012.03.005
Kuo, S. H., Tang, G., Louis, E. D., Ma, K., Babji, R., Balatbat, M., et al. (2013).
Lingo-1 expression is increased in essential tremor cerebellum and is present in
the basket cell pinceau. Acta Neuropathol. 125, 879–889. doi: 10.1007/s00401-
013-1108-7
Kuruvilla, R., Zweifel, L. S., Glebova, N. O., Lonze, B. E., Valdez, G., Ye, H.,
et al. (2004). A neurotrophin signaling cascade coordinates sympathetic neuron
development through differential control of TrkA trafficking and retrograde
signaling. Cell 118, 243–255. doi: 10.1016/j.cell.2004.06.021
Kwon, M., Fernández, J. R., Zegarek, G. F., Lo, S. B., and Firestein, B. L.
(2011). BDNF-promoted increases in proximal dendrites occur via CREB-
dependent transcriptional regulation of cypin. J. Neurosci. 31, 9735–9745.
doi: 10.1523/jneurosci.6785-10.2011
Laederich, M. B., Funes-Duran, M., Yen, L., Ingalla, E., Wu, X., Carraway, K. L.,
et al. (2004). The leucine-rich repeat protein LRIG1 is a negative regulator of
ErbB family receptor tyrosine kinases. J. Biol. Chem. 279, 47050–47056. doi: 10.
1074/jbc.m409703200
Lazo, O. M., Gonzalez, A., Ascaño, M., Kuruvilla, R., Couve, A., and Bronfman,
F. C. (2013). BDNF regulates Rab11-mediated recycling endosome dynamics to
induce dendritic branching. J. Neurosci. 33, 6112–6122. doi: 10.1523/jneurosci.
4630-12.2013
Ledda, F., Bieraugel, O., Fard, S. S., Vilar, M., and Paratcha, G. (2008). Lrig1 is an
endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream
signaling and biological responses to GDNF. J. Neurosci. 28, 39–49. doi: 10.
1523/jneurosci.2196-07.2008
Lee, R., Kermani, P., Teng, K. K., and Hempstead, B. L. (2001). Regulation of
cell survival by secreted proneurotrophins. Science 294, 1945–1948. doi: 10.
1126/science.1065057
Lewis, M., Arnot, C. J., Beeston, H., McCoy, A., Ashcroft, A. E., Gay, N. J., et al.
(2013). Cytokine spatzle binds to the Drosophila immunoreceptor toll with a
neurotrophin-like specificity and couples receptor activation. Proc. Natl. Acad.
Sci. U S A 110, 20461–20466. doi: 10.1073/pnas.1317002110
Liu, G., Gu, B., He, X. P., Joshi, R. B., Wackerle, H. D., Rodriguiz, R. M., et al.
(2013). Transient inhibition of TrkB kinase after status epilepticus prevents
development of temporal lobe epilepsy. Neuron 79, 31–38. doi: 10.1016/j.
neuron.2013.04.027
Liu, Y., Rutlin, M., Huang, S., Barrick, C. A., Wang, F., Jones, K. R., et al.
(2012). Sexually dimorphic BDNF signaling directs sensory innervation
of the mammary gland. Science 338, 1357–1360. doi: 10.1126/science.
1228258
Mandai, K., Guo, T., St Hillaire, C., Meabon, J. S., Kanning, K. C., Bothwell, M.,
et al. (2009). LIG family receptor tyrosine kinase-associated proteins modulate
growth factor signals during neural development. Neuron 63, 614–627. doi: 10.
1016/j.neuron.2009.07.031
Mandai, K., Reimert, D. V., and Ginty, D. D. (2014). Linx mediates interaxonal
interactions and formation of the internal capsule. Neuron 83, 93–103. doi: 10.
1016/j.neuron.2014.05.020
Mariga, A., Mitre, M., and Chao, M. V. (2016). Consequences of brain-derived
neurotrophic factor withdrawal in CNS neurons and implications in disease.
Neurobiol. Dis. doi: 10.1016/j.nbd.2016.03.009 [Epub ahead of print].
McAllister, A. K., Lo, D. C., and Katz, L. C. (1995). Neurotrophins regulate
dendritic growth in developing visual cortex. Neuron 15, 791–803. doi: 10.
1016/0896-6273(95)90171-x
McIlroy, G., Foldi, I., Aurikko, J., Wentzell, J. S., Lim, M. A., Fenton, J. C., et al.
(2013). Toll-6 and Toll-7 function as neurotrophin receptors in the Drosophila
melanogaster CNS. Nat. Neurosci. 16, 1248–1256. doi: 10.1038/nn.3474
Meabon, J. S., De Laat, R., Ieguchi, K., Wiley, J. C., Hudson, M. P., and Bothwell,
M. (2015). LINGO-1 protein interacts with the p75 neurotrophin receptor in
intracellular membrane compartments. J. Biol. Chem. 290, 9511–9520. doi: 10.
1074/jbc.m114.608018
Mi, S., Lee, X., Shao, Z., Thill, G., Ji, B., Relton, J., et al. (2004). LINGO-1 is a
component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci. 7,
221–228. doi: 10.1038/nn1188
Mi, S., Miller, R. H., Tang, W., Lee, X., Hu, B., Wu, W., et al. (2009).
Promotion of central nervous system remyelination by induced differentiation
of oligodendrocyte precursor cells. Ann. Neurol. 65, 304–315. doi: 10.1002/ana.
21581
Nguyen, K. Q., Rymar, V. V., and Sadikot, A. F. (2016). Impaired TrkB signaling
underlies reduced BDNF-mediated trophic support of striatal neurons in the
Frontiers in Cellular Neuroscience | www.frontiersin.org 9 August 2016 | Volume 10 | Article 199
Ledda and Paratcha Neurotrophic Signaling Modulation by LRR Proteins
R6/2 mouse model of Huntington’s disease. Front. Cell. Neurosci. 10:37. doi: 10.
3389/fncel.2016.00037
Okamura, Y., Kohmura, E., and Yamashita, T. (2011). TACE cleaves neogenin to
desensitize cortical neurons to the repulsive guidance molecule. Neurosci. Res.
71, 63–70. doi: 10.1016/j.neures.2011.05.012
Pachnis, V., Mankoo, B., and Costantini, F. (1993). Expression of the c-ret proto-
oncogene during mouse embryogenesis. Development 119, 1005–1017.
Paratcha, G., and Ledda, F. (2008). GDNF and GFRα: a versatile molecular
complex for developing neurons. Trends Neurosci. 31, 384–391. doi: 10.1016/j.
tins.2008.05.003
Panza, P., Sitko, A. A., Maischein, H. M., Koch, I., Flötenmeyer, M., Wright, G. J.,
et al. (2015). The LRR receptor Islr2 is required for retinal axon routing at the
vertebrate optic chiasm. Neural Dev. 10:23. doi: 10.1186/s13064-015-0050-x
Patel, T. D., Kramer, I., Kucera, J., Niederkofler, V., Jessell, T. M., Arber, S., et al.
(2003). Peripheral NT3 signaling is required for ETS protein expression and
central patterning of proprioceptive sensory afferents. Neuron 38, 403–416.
doi: 10.1016/s0896-6273(03)00261-7
Pérez, P., Coll, P. M., Hempstead, B. L., Martín-Zanca, D., and Chao, M. V. (1995).
NGF binding to the trk tyrosine kinase receptor requires the extracellular
immunoglobulin-like domains. Mol. Cell. Neurosci. 6, 97–105. doi: 10.
1006/mcne.1995.1010
Perez-Pinera, P., García-Suarez, O., Germanà, A., Díaz-Esnal, B., de Carlos,
F., Silos-Santiago, I., et al. (2008). Characterization of sensory deficits in
TrkB knockout mice. Neurosci. Lett. 433, 43–47. doi: 10.1016/j.neulet.2007.
12.035
Plotkin, J. L., Day, M., Peterson, J. D., Xie, Z., Kress, G. J., Rafalovich, I., et al.
(2014). Impaired TrkB receptor signaling underlies corticostriatal dysfunction
in Huntington’s disease. Neuron 83, 178–188. doi: 10.1016/j.neuron.2014.05.
032
Rauskolb, S., Zagrebelsky, M., Dreznjak, A., Deogracias, R., Matsumoto, T., Wiese,
S., et al. (2010). Global deprivation of brain-derived neurotrophic factor in the
CNS reveals an area-specific requirement for dendritic growth. J. Neurosci. 30,
1739–1749. doi: 10.1523/jneurosci.5100-09.2010
Ray, M. T., Weickert, C. S., and Webster, M. J. (2014). Decreased BDNF
and TrkB mRNA expression in multiple cortical areas of patients with
schizophrenia and mood disorders. Transl. Psychiatry 4:e389. doi: 10.1038/tp.
2014.26
Ray, M. T., Weickert, C. S., Wyatt, E., andWebster, M. J. (2011). Decreased BDNF,
trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals
with schizophrenia and mood disorders. J. Psychiatry Neurosci. 36, 195–203.
doi: 10.1503/jpn.100048
Reichardt, L. F. (2006). Neurotrophin-regulated signalling pathways. Philos. Trans.
R. Soc. Lond. B Biol. Sci. 361, 1545–1564. doi: 10.1098/rstb.2006.1894
Satoh, J., Tabunoki, H., Yamamura, T., Arima, K., and Konno, H. (2007). TROY
and LINGO-1 expression in astrocytes and macrophages/microglia in multiple
sclerosis lesions.Neuropathol. Appl. Neurobiol. 33, 99–107. doi: 10.1111/j.1365-
2990.2006.00787.x
Schuchardt, A., D’Agati, V., Larsson-Blomberg, L., Costantini, F., and Pachnis,
V. (1994). Defects in the kidney and enteric nervous system of mice lacking
the tyrosine kinase receptor Ret. Nature 367, 380–383. doi: 10.1038/36
7380a0
Shattuck, D. L., Miller, J. K., Laederich, M., Funes, M., Petersen, H., Carraway,
K. L., et al. (2007). LRIG1 is a novel negative regulator of the Met receptor
and opposes Met and Her2 synergy. Mol. Cell. Biol. 27, 1934–1946. doi: 10.
1128/mcb.00757-06
Shmelkov, S. V., Hormigo, A., Jing, D., Proenca, C. C., Bath, K. G., Milde, T.,
et al. (2010). Slitrk5 deficiency impairs corticostriatal circuitry and leads to
obsessive-compulsive-like behaviors in mice. Nat. Med. 16, 598–602, 591p
following 602. doi: 10.1038/nm.2125
Simion, C., Cedano-Prieto, M. E., and Sweeney, C. (2014). The LRIG family:
enigmatic regulators of growth factor receptor signaling. Endocr. Relat. Cancer
21, R431–R443. doi: 10.1530/ERC-14-0179
Soba, P., Han, C., Zheng, Y., Perea, D., Miguel-Aliaga, I., Jan, L. Y., et al.
(2015). The Ret receptor regulates sensory neuron dendrite growth and integrin
mediated adhesion. Elife 4:e05491. doi: 10.7554/elife.05491
Song, M., Giza, J., Proenca, C. C., Jing, D., Elliott, M., Dincheva, I., et al. (2015).
Slitrk5 mediates BDNF-dependent TrkB receptor trafficking and signaling.
Dev. Cell 33, 690–702. doi: 10.1016/j.devcel.2015.04.009
Stuart, H. M., Roberts, N. A., Burgu, B., Daly, S. B., Urquhart, J. E., Bhaskar, S.,
et al. (2013). LRIG2 mutations cause urofacial syndrome. Am. J. Hum. Genet.
92, 259–264. doi: 10.1016/j.ajhg.2012.12.002
Sugaya, R., Ishimaru, S., Hosoya, T., Saigo, K., and Emori, Y. (1994). A Drosophila
homolog of human proto-oncogene ret transiently expressed in embryonic
neuronal precursor cells including neuroblasts and CNS cells. Mech. Dev. 45,
139–145. doi: 10.1016/0925-4773(94)90027-2
Ultsch, M. H., Wiesmann, C., Simmons, L. C., Henrich, J., Yang, M., Reilly, D.,
et al. (1999). Crystal structures of the neurotrophin-binding domain of TrkA,
TrkB and TrkC. J. Mol. Biol. 290, 149–159. doi: 10.1006/jmbi.1999.2816
Urfer, R., Tsoulfas, P., O’Connell, L., Shelton, D. L., Parada, L. F., and Presta,
L. G. (1995). An immunoglobulin-like domain determines the specificity of
neurotrophin receptors. EMBO J. 14, 2795–2805.
van Erp, S., van den Heuvel, D. M., Fujita, Y., Robinson, R. A., Hellemons, A. J.,
Adolfs, Y., et al. (2015). Lrig2 negatively regulates ectodomain shedding of axon
guidance receptors by ADAM proteases. Dev. Cell 35, 537–552. doi: 10.1016/j.
devcel.2015.11.008
Van Schijndel, J. E., Van Zweeden, M., Van Loo, K. M., Djurovic, S.,
Andreassen, O. A., Hansen, T., et al. (2011). Dual association of a TRKA
polymorphism with schizophrenia. Psychiatr. Genet. 21, 125–131. doi: 10.
1097/ypg.0b013e3283437194
Wang, K. C., Kim, J. A., Sivasankaran, R., Segal, R., andHe, Z. (2002). P75 interacts
with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature
420, 74–78. doi: 10.1038/nature01176
Wickramasinghe, S. R., Alvania, R. S., Ramanan, N., Wood, J. N., Mandai, K., and
Ginty, D. D. (2008). Serum response factor mediates NGF-dependent target
innervation by embryonic DRG sensory neurons. Neuron 58, 532–545. doi: 10.
1016/j.neuron.2008.03.006
Windisch, J. M., Auer, B., Marksteiner, R., Lang, M. E., and Schneider, R. (1995).
Specific neurotrophin binding to leucine-richmotif peptides of TrkA and TrkB.
FEBS Lett. 374, 125–129. doi: 10.1016/0014-5793(95)01047-i
Wirth, M. J., Brun, A., Grabert, J., Patz, S., and Wahle, P. (2003). Accelerated
dendritic development of rat cortical pyramidal cells and interneurons after
biolistic transfection with BDNF and NT4/5. Development 130, 5827–5838.
doi: 10.1242/dev.00826
Woolf, A. S., Stuart, H. M., Roberts, N. A., McKenzie, E. A., Hilton, E. N., and
Newman, W. G. (2014). Urofacial syndrome: a genetic and congenital disease
of aberrant urinary bladder innervation. Pediatr. Nephrol. 29, 513–518. doi: 10.
1007/s00467-013-2552-2
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Ledda and Paratcha. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution and reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Cellular Neuroscience | www.frontiersin.org 10 August 2016 | Volume 10 | Article 199
